Generic Name:
Peginterferon alfa-2a and Ribavirin
Project Status:
Complete
Therapeutic Area:
Hepatitis C, chronic
Manufacturer:
Hoffman-La Roche Ltd.
Brand Name:
Pegasys RBV
Project Line:
Reimbursement Review
Project Number:
SR0013-000
Details
Submission Type:
Initial
Indications:
Hepatitis C, chronic
Recommendation Type:
List in a similar manner to other drugs in class
Final Recommendation:
Recommendation:
List in a similar manner to other interferon plus ribavirin products used in the treatment of chronic hepatitis C.